Table 1. Open in new tab Clinical... | Oxford Academic

Table 1.

Open in new tab

Clinical Characteristics of Patients With Recurrent Medulloblastoma

Patients With Recurrence (n = 82)
Characteristic	n	%
Sex
Male	52	63.4
Female	30	36.6
Age, years
≤29	43	52.4
>29	39	47.6
Metastasis^*
M+	11	13.4
M0	37	45.1
Unknown	34	41.5
Risk group^*
Standard	30	36.6
High	31	37.8
Unknown	21	25.6
Histology
Classic	30	36.6
Desmoplastic	28	34.1
Large cell/anaplastic	3	3.7
Unknown	21	25.6
Initial localization
Vermis	22	26.8
Fourth ventricle	8	9.8
Left cerebellum	26	31.7
Right cerebellum	24	29.3
Other	9	11.0
Unknown	7	8.5
First-line treatment
Initial surgery
Gross total resection	41	50.0
Near-total resection	3	3.7
Subtotal resection	30	36.6
Biopsy	1	1.2
Unknown	7	8.5
Radiation therapy	78	95.1
Chemotherapy
Neoadjuvant	16	19.5
Concurrent	9	11.0
Adjuvant	27	32.9
Intrathecal	12	14.6

Patients With Recurrence (n = 82)
Characteristic	n	%
Sex
Male	52	63.4
Female	30	36.6
Age, years
≤29	43	52.4
>29	39	47.6
Metastasis^*
M+	11	13.4
M0	37	45.1
Unknown	34	41.5
Risk group^*
Standard	30	36.6
High	31	37.8
Unknown	21	25.6
Histology
Classic	30	36.6
Desmoplastic	28	34.1
Large cell/anaplastic	3	3.7
Unknown	21	25.6
Initial localization
Vermis	22	26.8
Fourth ventricle	8	9.8
Left cerebellum	26	31.7
Right cerebellum	24	29.3
Other	9	11.0
Unknown	7	8.5
First-line treatment
Initial surgery
Gross total resection	41	50.0
Near-total resection	3	3.7
Subtotal resection	30	36.6
Biopsy	1	1.2
Unknown	7	8.5
Radiation therapy	78	95.1
Chemotherapy
Neoadjuvant	16	19.5
Concurrent	9	11.0
Adjuvant	27	32.9
Intrathecal	12	14.6

^*At initial diagnosis.

Table 1.

Open in new tab

Clinical Characteristics of Patients With Recurrent Medulloblastoma

Patients With Recurrence (n = 82)
Characteristic	n	%
Sex
Male	52	63.4
Female	30	36.6
Age, years
≤29	43	52.4
>29	39	47.6
Metastasis^*
M+	11	13.4
M0	37	45.1
Unknown	34	41.5
Risk group^*
Standard	30	36.6
High	31	37.8
Unknown	21	25.6
Histology
Classic	30	36.6
Desmoplastic	28	34.1
Large cell/anaplastic	3	3.7
Unknown	21	25.6
Initial localization
Vermis	22	26.8
Fourth ventricle	8	9.8
Left cerebellum	26	31.7
Right cerebellum	24	29.3
Other	9	11.0
Unknown	7	8.5
First-line treatment
Initial surgery
Gross total resection	41	50.0
Near-total resection	3	3.7
Subtotal resection	30	36.6
Biopsy	1	1.2
Unknown	7	8.5
Radiation therapy	78	95.1
Chemotherapy
Neoadjuvant	16	19.5
Concurrent	9	11.0
Adjuvant	27	32.9
Intrathecal	12	14.6

Patients With Recurrence (n = 82)
Characteristic	n	%
Sex
Male	52	63.4
Female	30	36.6
Age, years
≤29	43	52.4
>29	39	47.6
Metastasis^*
M+	11	13.4
M0	37	45.1
Unknown	34	41.5
Risk group^*
Standard	30	36.6
High	31	37.8
Unknown	21	25.6
Histology
Classic	30	36.6
Desmoplastic	28	34.1
Large cell/anaplastic	3	3.7
Unknown	21	25.6
Initial localization
Vermis	22	26.8
Fourth ventricle	8	9.8
Left cerebellum	26	31.7
Right cerebellum	24	29.3
Other	9	11.0
Unknown	7	8.5
First-line treatment
Initial surgery
Gross total resection	41	50.0
Near-total resection	3	3.7
Subtotal resection	30	36.6
Biopsy	1	1.2
Unknown	7	8.5
Radiation therapy	78	95.1
Chemotherapy
Neoadjuvant	16	19.5
Concurrent	9	11.0
Adjuvant	27	32.9
Intrathecal	12	14.6

^*At initial diagnosis.